Computer-aided Drug Discovery Market 2021 Segmentation, Statistics, Top Manufacturers, Regional Analysis and Forecast to 2028


News provided by

Shibuya Data Count

Jan 05, 2022, 01:46 EST


Shibuya-ku, Tokyo, Japan, Japan, Jan 05, 2022, 01:46 /Comserve / -- According to Research Dive analysis, the global computer-aided drug discovery market is estimated to generate a revenue of $7,915.9 million by 2028, increasing from $2,746.9 million in 2020, at a healthy CAGR of 15.0%.

According to Research Dive analysis, the global computer-aided drug discovery market is estimated to generate a revenue of $7,915.9 million by 2028, increasing from $2,746.9 million in 2020, at a healthy CAGR of 15.0%.

Impact Analysis of COVID-19 on the Global Computer-aided Drug Discovery Market:

The global computer aided drug discovery market experienced a higher growth rate during the Covid-19 pandemic. Due to increasing number of infection cases, worldwide, lack of a proper potent drug for the treatment and quick mutation in the viral genome, the computer aided drug discovery market has observed an exponential growth. The coronavirus pandemic has pressurized the researchers and scientists, from across the world to initiate their research for studying the viral genome in detail and develop a potent drug using computational software. Also, some major market players have come forward and collaborated together to work on COVID-19 drug development using computer aided drug discovery. Such factors are attributed to the growth of the market in the coming years.

Download Sample PDF Of This Report:- https://www.sdki.jp/sample-request-115196

Computer-aided Drug Discovery Market Analysis:

The computer aided drug discovery market experienced appreciable growth due to increasing cases of chronic diseases. Continuous rising number of unknown diseases has boosted the research activities and experiments. Computer aided drug discovery helps in studying the interaction between the target biological molecule and its corresponding ligand. It also helps in drug development, is a cost effective approach and takes approximately less time compared to wet laboratory experiments. Such factors are expected to drive the market of computer aided drug discovery in the forecast timeframe. Furthermore, increasing integration of artificial intelligence with computer aided drug discovery is anticipated to raise the market share in the global computer aided drug discovery market.

However, lack of skilled professionals to operate and handle software for computer aided drug discovery is expected to restrain the market growth. The computer aided drug discovery tools require a complete database of 3 D structure of proteins and other biomolecules. In case of unknown disease or less studied disease, the tools are unable to provide any good result. This factor is also likely to hamper the market growth.

Major technological advancements in computer aided drug discovery is expected to open various opportunities for the market in the future. The use of computer-aided drug discovery (CADD), is widely used by drug discovery companies to develop drugs against the diseases in a cost effective and rapid way. This software technology is now-a-days integrated with emerging technologies such as machine learning (ML) and artificial intelligence (AI) which drive the research programs in the biotechnological and pharmaceutical industries. Many companies have got a tremendous opportunity to mark their presence in the global market by opting for collaborations and partnerships with key players working in the artificial intelligence and computer aided drug discovery field.

Based on type, the global computer aided drug discovery market is divided into structure based drug design, ligand-based drug design and sequence-based approaches.

The structure based drug design sub-segment shall have the fastest market growth and it is anticipated to generate a revenue of $ 2,539.4 million by 2028.

Based on therapeutic area, the market is classified into the oncology, neurology, cardiovascular disease, respiratory disease, diabetes, and others. The oncology sub-segment garnered $ 636.6 million in 2020 and is projected to grow exponentially by 2028.

Based on the end users, the market is segmented into the pharmaceutical companies, biotechnology companies, and research laboratories. The research laboratories sub-segment is predicted to be growing significantly and it is expected to cross $ 3,269.7 million by 2028.

Download Sample PDF Of This Report:- https://www.sdki.jp/sample-request-115196

Based on geographical scope, the market was investigated across North America, Europe, Asia-Pacific, and LAMEA. The Asia-Pacific application computer aided drug discovery market is anticipated to rise at a growth rate of 16.4% by 2028 from the revenue generated in 2020.

The companies involved in the global computer-aided drug discovery market are BOCSCI Inc., Bioduro-Sundia, Schrödinger, Inc., Aragen Life Sciences Pvt. Ltd., Aris Pharmaceuticals, Inc, Charles River Laboratories, Bayer AG, AstraZeneca, and Albany Molecular Research Inc. (AMRI)

The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.


For more information, please contact:

Lauren Brown

Shibuya Data Count
Email: sales@sdki.jp
Tel: + 81 50 50509159

Related Links
https://www.sdki.us/



Also from this source


AFP/ATL Machines Market: Qualitative Analysis, Quantitative Analysis, Forecast up to 2030

The report predicts the global AFP/ATL machines market to grow with a CAGR of Healthy over the forec